Yy. Zou et al., ANTITUMOR-ACTIVITY OF FREE AND LIPOSOME-ENTRAPPED ANNAMYCIN, A LIPOPHILIC ANTHRACYCLINE ANTIBIOTIC WITH NON-CROSS-RESISTANCE PROPERTIES, Cancer research, 54(6), 1994, pp. 1479-1484
The lipophilic anthracycline antibiotic annamycin (Ann) was entrapped
in liposomes of different size [median diameter: 1.64 mu m, multilamel
lar liposomal Ann (L-Ann); 0.030 mu m, small unilamellar Ann (S-Ann)]
with >90% entrapment efficiency and tested in vitro against four pairs
of sensitive and multidrug-resistant (MDR) tumor cell lines and in vi
vo by the i.v. route in five tumor models: advanced s.c. B16 melanoma;
s.c. M5076 reticulosarcoma; lung metastases of Lewis lung carcinoma;
and s.c. KB and KB-V1 xenografts in nude mice. Predetermined optimal d
oses of the different formulations were used and the results were comp
ared with doxorubicin (Dox). In vitro, Ann, either in suspension in 10
% dimethyl sulfoxide (F-Ann) (1 mg/ml) or entrapped in liposomes, was
able to partially overcome resistance in all four pairs of sensitive a
nd MDR KB, 8226, P388, and CEM cell lines (resistance indexes 63, 269,
333, and 356 for Dox versus 4, 5, 19, and 8.7 for L-Ann, respectively
). In vivo, both F-Ann and liposome-entrapped Ann were slightly more e
ffective than Dox in inhibiting the growth of advanced s.c. B16 melano
ma tumors. L-Ann was markedly more effective than Dox and moderately m
ore effective than F-Ann in prolonging the life span of animals bearin
g s.c. M5076 and lung metastases of Lewis lung carcinoma tumors. All d
rugs were equally effective at optimal doses in delaying the growth of
s.c. KB xenografts, whereas all Ann formulations were markedly more e
ffective than Dox in delaying the growth of s.c. KB-V1 (MDR) xenograft
s. In all in vivo experiments, S-Ann was consistently more effective t
han L-Ann and L-Ann was more effective than F-Ann. These results indic
ate that (a) Ann is more effective than Dox by the i.v. route against
several tumor models and that MDR tumors are partially not cross-resis
tant to Ann both in vitro and in vivo, (b) liposomes enhance the in vi
vo antitumor properties of Ann, and (c) small liposomes are more effec
tive than large liposomes in enhancing Ann antitumor activity.